Omeros | OMER - Capital De Empréstimo





Capital De Empréstimo Alterar Data
Adma Biologics USD 69.33M 750K 2025-12
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Cytokinetics USD 247.21M 868.77M 2026-03
Gilead Sciences USD 22.13B 6M 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
Immunic USD 0 0 2024-06
Insmed USD 540.96M 1.24M 2025-12
Knight Therapeutics CAD 57.78M 26.92M 2025-12
MacroGenics USD 70M 256K 2025-12
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 367.66M 4.53M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Rockwell Medical USD 8.65M 89K 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Xoma USD 94.38M 7.82M 2025-09